Listen
MYDRANE (tropicamide, phenylephrine, lidocaine), mydriatic and anaesthetic
OPHTHALMOLOGY - New medicinal product
Opinions on drugs -
Posted on
Nov 10 2016
Reason for request
Inclusion
No clinical benefit demonstrated in obtaining mydriasis in cataract surgery when compared with other mydriatics.
- MYDRANE has Marketing Authorisation in cataract surgery for obtaining mydriasis and intraocular anaesthesia during the surgical procedure in adults.
- The intracameral route makes it fast-acting and eliminates the preoperative dilation phase, which enables the overall patient care time to be reduced, though not the surgery time.
- Its non-inferiority has been demonstrated compared to a standard pupil dilation protocol, that includes instillation of mydriatics in the form of eyedrops, in terms of obtaining sufficient mydriasis when performing capsulorhexis without any additional mydriatic treatment.
Clinical Benefit
| Substantial |
- |
Clinical Added Value
| no clinical added value |
- |
Therapeutic use
- |
English version
Contact Us
Évaluation des médicaments
